AMICAS — Merger or Acquisition (January 2010)
16 slides from AMICAS's merger presentation, Jan 28, 2010
Slide 1: Investor Presentation January 2010
Investor Presentation January 2010
Slide 2: Forward Looking Statements, Risk Factors & Non-GAAP
Forward Looking Statements, Risk Factors & Non-GAAP This presentation contains forward-looking statements about AMICAS and the proposed transaction. Such forward-looking statements are subject to the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results ma
Slide 3: Information Regarding the Solicitation of Proxies
Information Regarding the Solicitation of Proxies In connection with the proposed transaction, AMICAS has filed a proxy statement and relevant documents concerning the proposed transaction with the SEC. Shareholders of AMICAS are urged to read the proxy statement and other relevant materials because
Slide 4: Company Overview
Company Overview AMICAS is the #1 independent provider of health care image and information management solutions. 30 years focused on image and information management solutions 2003 acquisition of AMICAS provided platform of imaging solutions for small to mid-sized hospitals and ambulatory practices
Slide 5: Transaction Overview
Transaction Overview Based on 36,211,373 common shares outstanding, dilutive impact of options of 4,243,330 calculated using the treasury stock method, and 85,914 shares under the Employee Stock Purchase Plan, as of December 24, 2009. Net cash adjusted to reflect the amount by which the deferred rev
Slide 6: Board Recommendation
Board Recommendation The Board of Directors believes that a sale to Thoma Bravo at $5.35 per share in cash maximizes value for shareholders. Offers stockholders immediate and certain value in a volatile market and at an attractive valuation Thoma Bravo's guarantee of the full value of the transactio
Slide 7: Advantageous Time to Consider Sale
Recent trends create an advantageous time for shareholders to capture an attractive premium on top of twelve-month price appreciation. The health care information technology sector as a whole is trading at record levels; federal stimulus initiatives have provided a substantial boost to sector valuat
Slide 8: AMICAS: One Year Price Chart
AMICAS: One Year Price Chart Transaction Price per Share: $5.35 Stock Price Closing price: $4.38 On 12/23/2009 22.1% premium 52-week low (1): $1.51 on 2/3/09 254.3% premium LOI signing: $3.32 on 11/3/09 61.1% premium 52-week high (1): $4.71 on 12/7/09 13.6% premium (1) High and low prices exclude pe
Slide 9: AMICAS: Three Year Price Chart
AMICAS: Three Year Price Chart Transaction Price per Share: $5.35 Stock Price Closing price: $4.42 On 12/24/2009 21.0% premium 3-year low, excluding period post- TB transaction announcement: $1.32 on 11/24/09 305.3% premium 3-year high, excluding period post-TB transaction announcement: $4.71 on 12/
Slide 10: Select Public Company Comparables
Select Public Company Comparables The Thoma Bravo transaction implies valuation multiples higher than those of select health care image and information management companies (Merge Healthcare, Nighthawk Radiology, Virtual Radiologic, and Vital Images). Merger Consideration Mean Median Enterprise valu
Slide 11: Potential Operational Challenges
Potential Operational Challenges Expected growth rate for radiology IT is lower than that of the broader health care IT universe: Mature market for radiology and imaging systems Modest historical revenue growth; AMICAS CAGR of ~4% from CY2004 through CY2008 (negative for the period CY2005 to CY2008)
Slide 12: Competitive Pressures
Competitive Pressures Market Position Strong Weak High Low Strong Weak Market Position Competitive Threat Cardiology Radiology High Low Competitive Threat
Slide 13: Background of the Merger
Background of the Merger Date Event Circa August 12, 2009 Thoma Bravo ("TB") expressed interest in acquiring AMICAS at a price of $4.00 cash per share in a fully guaranteed transaction. AMICAS Board rejected the $4.00 per share offer, but expressed willingness to continue discussions on improved ter
Slide 14: Roadmap to Completion
Roadmap to Completion Merger Agreement Executed December 24, 2009 Go-Shop Period Began December 24, 2009 Transaction Announced December 28, 2009 Preliminary Proxy Filed January 8, 2010 SEC Comments to Proxy Received January 13, 2010 Definitive Proxy Filed January 15, 2010 Shareholder Record Date Jan
Slide 15: Thoma Bravo Agreement Maximizes Shareholder Value
Thoma Bravo Agreement Maximizes Shareholder Value The agreement with Thoma Bravo was fully negotiated and approved by an independent Board of Directors Attractive valuation at premium to historical trading range and peer group multiples Potential operational challenges as a stand-alone public compan
Slide 16: Thank You
Thank You Investor Presentation CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION This presentation, and the documents to which we refer you in this presentation, include forward-looking statements based on estimates and assumptions. There are forward-looking statements throughout this pre